颚éªã«æçå€ãæžãããããŠãææ°ã®æ€æ»ãã䜿ã£ãŠã¿ããããŸã£ããæžããªãã£ã話
ã1åã®æ€æ»ã§19çš®é¡ã®ãŠã€ã«ã¹ãš4çš®é¡ã®èãããããŸããââæè¿ãã¯ãªããã¯ã®åºåãšãã§ããããã®èŠãããããšããããŸãããïŒ
å€é
ç®ã®è¿
éPCRæ€æ»ã錻ãã®ã©ã®å¥¥ããç¶¿æ£ã§åã£ãæ€äœã§ã1æéãããããã«çµæãåºããæè¡ãšããŠã¯ããããªãšæããã§ãã
ãã ãããã䜿ãã°é¢šéªãžã®æçå€ã®ç¡é§æã¡ãæžããããââãããæ£é¢ããæ€èšŒããè«æãåºãŸããŠãææçå»ãšããŠã¯ããªãæ°ã«ãªã話ã ã£ãã®ã§ãæŽçããŠã¿ãŸãã
45%察45%ââäœãåããªãã£ã
2025幎5æãJAMA Internal Medicineã«å ±åãããã€ã®ãªã¹ã®ç ç©¶ã§ãã
察象ã¯16ã®èšºçæã«æ¥ãæ¥æ§åŒåžåšææçã®æ£è
ãã552人ãæ
åœå»ããæçå€ãåºããããããªãããšèããã±ãŒã¹ã«çµã£ãŠãã©ã³ãã ã«2矀ã«åããŠãŸãã
ä»å ¥çŸ€ïŒå€é ç®PCRã®çµæãå»åž«ã«é瀺ãã
å¯Ÿç §çŸ€ïŒæ€æ»ã¯ãããã©çµæã¯é瀺ããªãïŒéåžžã®ã±ã¢ïŒ
ã§ãçµæã
æçå€ã®åŠæ¹çã¯45%察45%ã
ãŸããã®åçãæ€æ»ããŠããããªããŠããå€ãããªãã£ãã
Hay AD, et al. Rapid Respiratory Microbiological Point-of-Care Testing and Antibiotic Use in Primary Care: A Randomized Clinical Trial. JAMA Intern Med. 2026;186(7):817-826. doi:10.1001/jamainternmed.2026.1426
ãªãã§æžããªãã£ãã®ãïŒ
ãããé¢çœããŠããäœãèµ·ããªãã£ãããããããªããã§ãããã
ãŠã€ã«ã¹ãèŠã€ãã£ã人ã§ã¯ã確ãã«æçå€ã®åŠæ¹ã¯æžã£ãŠããããŠã€ã«ã¹ã ããæçå€ã¯ãããªããããšãã倿ãåããã
ãšãããââçŽåæ°ã§äœãæ€åºãããªãã£ããã§ãã
äœãåºãªãã£ã人ã§ã¯ãéã«åŠæ¹ãå¢ããã45%ãã61%ã«ã
ãªãããšãããšããã®ããã«æ€æ»ã¯èºççèãã€ã³ãã«ãšã³ã¶èãšãã£ããããããåŒåžåšææã®çްèãã調ã¹ãŠããªããã ããããŠã€ã«ã¹ãé°æ§ãéå®åèãé°æ§ããšãªããšãããããæ®éã®çŽ°èææãªã®ããããšèªãŸããŠããŸãæ§é ãããã
æžã£ãåãšå¢ããåããããã«çžæ®ºããŠããã©ãã€ãŒãã
ãããæ£è
ããã®çç¶çµéã¯äž¡çŸ€ã§å·®ãªããåããã®ã¯åŠæ¹ã®ååžã ãã§ãæ£è
ããã«ãšã£ãŠã¯äœãå€ãã£ãŠããªãã
æ€æ»ã§ãç¯äººæ¢ãããããŠãã颚éªã®æ§é ã¯å€ãããªã
颚éªã£ãŠãå®ã¯ã軜çã§ããããšããããšãæå³ãšããŠå
å
ããŠããã§ããããéçåããã°èºçãšãå¥ã®èšºæåãæ¢ããã ãã颚éªãšããèšåºèšºæãä»ããæç¹ã§ãç
åäœãåæãããæ€æ»ã¯æ¬æ¥ãããªãã
åå ãŠã€ã«ã¹ã®ååããããããšããããŸããšãããããšã¯å¯Ÿççæ³ã§å€ãããªããã§ãã
ããã«ã颚éªãèµ·ãããŠã€ã«ã¹ã£ãŠæ¬åœã«ããããããŠã19çš®é¡èª¿ã¹ããšããã§æ°·å±±ã®äžè§ããæ€æ»ããã°çå®ããããããšããåæèªäœããæã£ãŠããã»ã©åŒ·ããªãã
æçå€ãæžããã®ã«æ¬åœã«å¹ãã®ã¯äœã
å®ã¯ã颚éªãžã®æçå€åŠæ¹ãæžãã广ã瀺ãããŠããã®ã¯ãççã®çšåºŠãèŠãæ€æ»ãšãã³ãã¥ãã±ãŒã·ã§ã³æè¡ã®èšç·Žã®ã»ãããªãã§ãããã
ãç¯äººæ¢ãããããªããŠããã©ã®ãããéããããæž¬ã£ãŠããããæ£è
ããã«ã¡ãããšäŒããåã
çµå±ãç®ã®åã®äžäººãèŠãŠãããã¯é¢šéªã§ãããšå€æããããããã¡ããšèª¬æã§ããããšããããŠãããåãæ¢ããŠããããå»åž«-æ£è é¢ä¿ãæ€æ»ãã¬ã€ãã©ã€ã³ã®æšå¥šæã«å€æãè©ä»£ãããããããšããŠããããŸããããªãã
ã¡ãªã¿ã«2025幎ãç±³åœã®èžéšåŠäŒïŒATSïŒãåžäžèºçã®ã¬ã€ãã©ã€ã³ãæ¹å®ãããã§ããã©ããŠã€ã«ã¹éœæ§æã®æèè¬ãããã£ãŠç±³åœææçåŠäŒïŒIDSAïŒãšæèŠãå²ããŠãIDSAãæ¿èªãèŠéãã£ãŠããç°äŸã®å±éã«ãªã£ãŠãŸããããšããã³ã¹ããªããšããã©ã£ã¡åŽã«åããããšããåãã¯ãå°éå®¶ã®éã§ããŸã æºããŠããé£ããåé¡ã§ãã
ãåºãæ¹ãå®å
šãã¯ãæã£ãŠããã»ã©èªæãããªããåºããªãæ¹ãå®å
šãªã·ãã¥ãšãŒã·ã§ã³ããæç¢ºã«ååšããã
ââãã®ATSãšIDSAã®å¯Ÿç«ã®äžèº«ããããšããã³ã¹ããªãå Žé¢ã§ã©ã£ã¡ã«èžã¿èŸŒããããšãã倿ããã»ã¹ã«ã€ããŠã¯ãVoicyã®ã¬ã®ã¥ã©ãŒæŸéã§è©³ããã話ãããŠããŸãã
ãããã質å
å€é ç®PCRã§19çš®é¡ã調ã¹ããããªãã颚éªã®åå ãç¹å®ã§ããããããªãã§ããïŒ
ãããèœãšã穎ã§ã颚éªãèµ·ãããŠã€ã«ã¹ã£ãŠæ¬åœã«ããããããã®ã§ã19çš®é¡èª¿ã¹ãŠãååè¿ãã¯ãäœãæ€åºãããªãããã§ããããæ€æ»ãæããŠããã®ã¯æ°·å±±ã®äžè§ã§ãã調ã¹ãã°çå®ããããããšããåæèªäœããæã£ãŠããã»ã©åŒ·ããªããã§ãã
ããã颚éªã®ãšãã«æçå€ãæžããæ¹æ³ã£ãŠäœããªããã§ããïŒ
ããã广ã瀺ãããŠããã®ã¯ãå®ã¯ãççã®çšåºŠãèŠãæ€æ»ããã³ãã¥ãã±ãŒã·ã§ã³æè¡ã®èšç·Žããªãã§ããç¯äººæ¢ãã®æ€æ»ãããªããŠããã©ã®ãããéããããæž¬ã£ãŠããããæ£è ããã«ãã¡ããšäŒããåã®æ¹ãå¹ãã£ãŠããââãããããã倧äºãªãã€ã³ãã ãšæã£ãŠãŸãã
ãã®æ€æ»ãæ¥æ¬ã§ãåããããã¿ããã§ããã©ãåããæ¹ãããã§ããïŒ
ä¿éºé©çšã§ãçªå£è² æ
ã§5,000åãããããããŸãããäžè¬çãªé¢šéªã®å€æ¥ã§ã¯æ£è
ããã®è»¢åž°ãæ¹åããªããšããããŒã¿ãåºãŠããã®ã§ããå®å¿ã®ããã«ããšããçç±ã ãã§åããã®ã¯ã¡ãã£ãšãã£ãããªãããªãšãå
ç«äžå
šãããæ¹ãªã©ãçµæã§ç®¡çãå®éã«å€ããå Žé¢ã§ã¯ç§ã䜿ãããšããããŸãã
ð Voicyã§èŽã
